Recordati Industria Chimica e Farmaceutica S.p.A. (BIT:REC)
48.88
+0.40 (0.83%)
At close: Mar 27, 2026
BIT:REC Revenue
Recordati Industria Chimica e Farmaceutica had revenue of 632.32M EUR in the quarter ending September 30, 2025, with 13.44% growth. This brings the company's revenue in the last twelve months to 2.55B, up 12.58% year-over-year. In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B with 12.45% growth.
Revenue (ttm)
2.55B
Revenue Growth
+12.58%
P/S Ratio
3.82
Revenue / Employee
588.40K
Employees
4,583
Market Cap
10.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.34B | 259.23M | 12.45% |
| Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
| Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
| Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
| Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
| Dec 31, 2019 | 1.48B | 129.61M | 9.59% |
| Dec 31, 2018 | 1.35B | 64.11M | 4.98% |
| Dec 31, 2017 | 1.29B | 134.18M | 11.63% |
| Dec 31, 2016 | 1.15B | 106.27M | 10.14% |
| Dec 31, 2015 | 1.05B | 60.32M | 6.11% |
| Dec 31, 2014 | 987.36M | 45.73M | 4.86% |
| Dec 31, 2013 | 941.63M | 113.31M | 13.68% |
| Dec 31, 2012 | 828.32M | 66.28M | 8.70% |
| Dec 31, 2011 | 762.04M | 33.90M | 4.66% |
| Dec 31, 2010 | 728.13M | -19.39M | -2.59% |
| Dec 31, 2009 | 747.52M | 57.89M | 8.39% |
| Dec 31, 2008 | 689.63M | 61.20M | 9.74% |
| Dec 31, 2007 | 628.44M | 52.25M | 9.07% |
| Dec 31, 2006 | 576.19M | 106.00K | 0.02% |
| Dec 31, 2005 | 576.08M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| Safilo Group | 983.38M |
| EL.En. | 590.85M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 487.08M |
| Svas Biosana | 134.95M |
| Pharmanutra | 133.97M |
Recordati Industria Chimica e Farmaceutica News
- 8 hours ago - CVC Offers â¬10.9B Takeover for Recordati at 12% Premium - GuruFocus
- 4 weeks ago - Amarin Corp Q4 2025 Earnings Call Transcript - Benzinga
- 8 months ago - Italy's Recordati CEO sees rare disease drugs exempt from U.S. tariffs - Reuters
- 8 months ago - Five years after COVID, pharma shares languish in US policy limbo - Reuters
- 11 months ago - RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2% - GlobeNewsWire
- 5 years ago - 5 High-Quality Stocks in the Mediterranean - GuruFocus